Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, AstraZeneca Pharma India has informed that it enclosed the Notice of the 43rd Annual General Meeting of the Company scheduled to be held on Monday, August 8, 2022 at 3.00 pm (IST) through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM). The Notice is being sent to the members of the Company through electronic mode. The said Notice and the Annual Report for the financial year ended March 31, 2022 is available on the website of the Company at www.astrazeneca.com/india.
The above information is a part of company’s filings submitted to BSE.
